Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2026HaematologicaOpen Access

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway"

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJing BaoYFYuan FangSNShiwei Ni

Discussion

Loading...

Member takes

Overview

This commentary discusses NLRP6 modulation to understand its effects on graft-versus-host disease, indicating potential therapeutic strategies.

Key Points

  • The aim is to clarify how NLRP6 modulation affects T cell activation in graft-versus-host disease.
  • Commentary on the role of NLRP6 in donor T cell activation.
  • Analysis of the ZAP-70-Erk signaling pathway in graft-versus-host disease.
  • NLRP6 is pivotal in regulating donor T cell activation.
  • Modulation of NLRP6 may define a therapeutic window in managing graft-versus-host disease.

Cite This Study

Bao et al. (2026) studied this question.

synapsesocial.com/papers/6a65a306d3aea3239cd7659ehttps://doi.org/10.3324/haematol.2026.301609
View Full Paper
Ask AI
Bookmark
Share